Загрузка...
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
Terbium-149 is among the most interesting therapeutic nuclides for medical applications. It decays by emission of short-range α-particles (E(α) = 3.967 MeV) with a half-life of 4.12 h. The goal of this study was to investigate the anticancer efficacy of a (149)Tb-labeled DOTA-folate conjugate (cm09)...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978496/ https://ncbi.nlm.nih.gov/pubmed/24633429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph7030353 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|